Persephone Persephone - A First-Of-Its-Kind Synbiotic Newly released data shows that nine in ten babies lack critical gut ...

Persephone First-of-Its-Kind Infant Synbiotic In just over a month, 10,000 parents and caregivers joined the waitlist for Persephone’s science-driven synbiotic designed to restore critical gut ...

“The microbiome is a new pillar of biology, and it has been historically untapped,” said Stephanie Culler, co-founder and CEO of Persephone Biosciences, in an interview Tuesday. Her company, a ...

SAN DIEGO, Calif.--(BUSINESS WIRE)--Persephone Biosciences Inc., (“Persephone”) a privately held, data-driven microbiome-focused biotechnology company, today announced that it has entered into a ...

SAN DIEGO--(BUSINESS WIRE)--Persephone Biosciences Inc., a synthetic biology company reimagining patient and infant health through the development of microbiome-based medicines, today announced that ...